Abstract:e12591 Background: Breast cancer is the most commonly diagnosed female cancer worldwide and the most common cause of cancer mortality in women. Surgical treatment of early breast cancer includes lumpectomy or mastectomy with or without reconstruction. Despite the surgeon’s best effort to perform a radical resection of the breast tissue during mastectomy to achieve locoregional control, residual fibroglandular tissue was found in 20% of breasts on postoperative breast MRI, which carries a risk of recurrence. Younger women with breast cancer have inferior survival rates despite receiving more aggressive therapy. Tumors in young women are more likely to be poorly differentiated, hormone receptor-negative, have a high proliferation index, and more lymphovascular invasion, which is partially explained by patients’ genetic profile. Another factor that could contribute to poor outcomes is the advanced stage at the time of diagnosis, including larger tumor size and higher rates of axillary lymph node positivity. This knowledge has motivated us to conduct this study that is dedicated to looking at the recurrence rate in young females following mastectomy. Methods: This is a retrospective study that collected data from young female patients who were diagnosed with breast cancer between January 2010 and August 2018, had an age at diagnosis of 18-45 years old, and underwent unilateral or bilateral mastectomy with or without reconstruction. The study also looked at the patient’s risk factors and genetic profile. Results: A total of 115 patients were diagnosed with early-stage breast cancer between January 2010 and August 2018 and underwent mastectomy. 81.74% were Caucasian females, and 8.7% were African American females. The mean age of diagnosis was 36.9 years. The mean BMI was 30.5 kg/m2. 59.13% of patients had a family history of breast cancer. The most common genetic mutations were BRCA1 at 7.83% and BRCA2 at 8.7%. 71% of patients underwent a bilateral mastectomy. 76% of patients had reconstruction. 77% of tumors were ER-positive, 68% PR-positive, and 26% HER2-positive. 49.4% of tumors were Nottingham grade 3. 52% of patients had no nodal involvement, while 35% had N1 disease. 34.6% had lymphovascular invasion. We found that 18/115 patients had recurrence of breast cancer following mastectomy. 5/17 patients had locoregional recurrence, while 12/17 patients had a distant recurrence; 1 patient’s recurrence data was unavailable. The median time to recurrence was 1147.5 days (335 to 3107). The 5-year recurrence free survival rate is 86% ± 3%. Conclusions: Our study found that 15.65% of young females had recurrence after mastectomy. To our knowledge, this is the first dedicated study to look at the recurrence rate after mastectomy in this young, high-risk patient population. Our study aims to encourage larger studies in young females with breast cancer to help tailor the treatment plan in this population.

Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer surveillance after breast-conserving surgery.

Time distributions and prognosis factors of breast cancer recurrence in different sites after operation.

Time distribution of breast cancer recurrence in different sites after surgical operation

Time-varying Pattern of Recurrence Risk for Chinese Breast Cancer Patients

Mammographic surveillance after breast cancer

Isolated Locoregional Recurrence Patterns of Breast Cancer after Mastectomy and Adjuvant Systemic Therapies in the Contemporary Era

Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy

Comparison of Time-Varying Pattern of Recurrence in Chinese Breast Cancer Patients with Different Molecular Subtypes: A Single-Center Retrospective Study

Increased Mortality with Repeat Lumpectomy Alone after Ipsilateral Breast Tumor Recurrence.

Pathologic Characteristics of Breast Cancer that Predict for Local Recurrence After Lumpectomy Alone

Comparison of Time-Varying Recurrence Patterns in Breast Cancer Patients with Different Molecular Subtypes Treated from 2008 to 2012 and from 2013 to 2016: a Single-Center Retrospective Study

A surveillance method-oriented detection of post-operative spatial-temporal recurrence for non-small cell lung cancer.

Factors increasing local recurrence in breast-conserving surgery

Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving Surgery

The Recurrence Patterns and Post-Recurrence Survivals in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma (escc) Treated with Preoperative Paclitaxel/Cisplatin-Based Chemoradiotherapy.

Locoregional Recurrence Analysis in Young Women (≤35 Years) Receiving Mastectomy with Operable Breast Cancer

Breast cancer recurrence rate after mastectomy in young females.

Time Distribution of Recurrence Risk for Breast Cancer Patients Undergoing Surgery

Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management.

67P Analysis of Local-Regional Recurrence in Young Women (≤ 35Y) Receiving Mastectomy for Operable Breast Cancer